A bench of Acting Chief Justice Gita Mittal and Justice C Hari Shankar also issued notice to the Delhi Government on the petition which sought direction to identify and publicise the names of hospitals, laboratories and medical stores which will provide testing and treatment of Hepatitis C virus (HCV) free of cost in the national capital.
The matter was listed for further hearing on December 18.
"Globally it is estimated to have caused 1.34 million deaths in 2015, a number comparable to annual deaths caused by tuberculosis and higher than those caused by HIV," the petition said.
The PIL, filed by NGO Delhi Network of Positive People, through its president Paul Lhungdim, said HCV was a "life- threatening disease" and its treatment is expensive.
It said if medicine is denied in government hospitals, the patients may not even buy it, thus defeating the Delhi Government's aim to provide quality healthcare to all citizens.
"Most patients have been forced to go to the private sector which charges much high prices," advocate Shwetasree Majumder, appearing for the NGO, said.
The other petitioner, a Delhi resident infected with HIV and Hepatitis C, sought urgent hearing saying he was in urgent need of treatment for HCV but unable bear the expenses. Lack of adequate treatment could prove fatal for him, he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
